New scan could spot hidden tumors behind rare bone disease
NCT ID NCT07366099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new type of PET/CT scan using a tracer called Al18F-NOTA-LM3 to find tumors that cause tumor-induced osteomalacia (TIO), a rare condition where bones soften and weaken. Researchers will compare this new scan to the standard 68Ga-DOTATATE PET/CT in 40 adults with suspected or confirmed TIO. The goal is to see if the new method is more sensitive and specific at locating these tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Al18F-NOTA-LM3 (a radioactive tracer for PET/CT scans)
- What this could lead to
- If successful, this could provide a more accurate way to detect the tumors causing osteomalacia, leading to earlier treatment and better outcomes.
- What could go wrong
- This is a small pilot study with only 40 participants, so results may not apply to everyone. The new tracer may not prove better than existing methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR-INDUCED OSTEOMALACIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••